Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

mRNA, biotech

News and Trends 11 Jan 2023

AbbVie bets on Anima mRNA modulators to tackle cancer

AbbVie and Anima Biotech have announced a collaboration to discover and develop mRNA biology modulators for three targets in oncology and immunology. Anima Biotech will use its mRNA Lightning platform to discover novel mRNA biology modulators against the collaboration targets, providing AbbVie exclusive rights to license and further develop and commercialize the programs. “This collaboration […]

January 11, 2023 - 2 minutesmins - By Jim Cornall

drugs drug repurposing

In Depth 11 Jan 2023

Drug repurposing emerges as viable option for rare disease treatment

With few options available for the treatment of rare diseases, the practice of drug repurposing has gained traction as an effective strategy. With genome sequencing revealing new rare diseases, it is now known that at least 5% of the world population lives with a rare disease. Drug development must pick up the pace to keep […]

January 11, 2023 - 7 minutesmins - By Sachin Rawat

digital technology smartwatch

News and Trends 11 Jan 2023

2023 life sciences industry trends: adopting a digital-first mindset

By Pat Jenakanandhini, chief product officer, ArisGlobal With the new year here, life science organizations have reached technology crossroads in choosing whether to embrace a digital-first mindset and adopt innovative digital technologies or hold fast to legacy processes. Digital transformation has driven newer technologies designed to improve efficiency, patient care and workflows. Those who choose […]

January 11, 2023 - 4 minutesmins - By External Contributor

clinical trial research

News and Trends 11 Jan 2023

What the new year holds for clinical research

Catherine Gregor is the chief clinical trial officer at Florence Healthcare. The company’s clinical trial software is used in more than 12,000 research sites in 45 countries for management of documents, data, and workflows. We asked Gregor about the clinical trial technology landscape in 2023. Why is remote clinical research connectivity so important? Remote connectivity […]

January 11, 2023 - 6 minutesmins - By Jim Cornall

psychedelic research

News and Trends 11 Jan 2023

Silo Pharma looks into the 2023 psychedelics crystal ball

Labiotech had the opportunity to ask James Kuo, vice president of R&D at Silo Pharma Inc., about his predictions for the field of psychedelic research in 2023. Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease, and other rare […]

January 11, 2023 - 5 minutesmins - By Jim Cornall

clinical trial

News and Trends 11 Jan 2023

Clinical trends for 2023

By Richard Staines, account director, Optimum Strategic Communications Few would deny that the decade has had a turbulent start, but after the tragedies of the COVID-19 pandemic and the Ukraine war, there’s hope that 2023 will see a new wave of clinical research. Exciting new technologies such as gene editing, gene therapy and a next […]

January 11, 2023 - 8 minutesmins - By External Contributor

ADVERTISEMENT

biotech

News and Trends 11 Jan 2023

What’s in store for biotech in 2023?

Perhaps 2022 will best be remembered in the life science industry for the return of many of the face-to-face events that fell by the wayside during the COVID-19 pandemic. It might have been a mixed year for biotech companies, but 2023 is a new year, with new challenges, but also new opportunities. So what do […]

January 11, 2023 - 14 minutesmins - By Jim Cornall

Personalised personalized medicine

News and Trends 11 Jan 2023

2023: A pivotal time for medicine as it enters a new ‘personalized’ era

By Hakim Yadi, co-founder and CEO of Closed Loop Medicine The traditional healthcare delivery model is designed to cater to the masses, rather than the individual. Administering treatments based on the overall safety and efficacy demonstrated in large-scale clinical trials, and not taking into consideration individual responses to such treatments, is resulting in poorer outcomes […]

January 11, 2023 - 5 minutesmins - By External Contributor

drug discovery

News and Trends 11 Jan 2023

We DUB this target ‘druggable’

By Sheelagh Frame, CSO at Ubiquigent Modulation of the ubiquitin-proteasome system (UPS) presents a rich source for drug discovery. Recent years have seen the clinical validation of proteolysis-targeting chimeras (PROTACs) unlock the ability to drug the undruggable, by exploiting E3 ligases to mediate targeted protein degradation (TPD), paving the way to tackle exciting new drug […]

January 11, 2023 - 5 minutesmins - By External Contributor

Asia map

News and Trends 11 Jan 2023

Biotech in Asia: looking forward to 2023

Masahiko Hayakawa, head of targeted protein degradation at Astellas Pharma Inc., gives us some insights into the state of the biopharma industry in 2023. Astellas is a Japanese headquartered pharmaceutical company active in more than 70 countries around the world. It promotes a ‘focus area approach’ designed to identify opportunities for the continuous creation of […]

January 11, 2023 - 4 minutesmins - By Jim Cornall

2023 science

News and Trends 11 Jan 2023

Lifesciences and biotech in 2023

A Q&A with Bill Coyle, principal, ZS. ZS is a management consulting and technology firm focused on transforming global healthcare. In some ways, 2022 could be seen as a challenging year—at least financially—in biotech. Do you see those trends continuing? Although we see overall sentiments to invest in biotech turning positive in 2023 after a […]

January 11, 2023 - 7 minutesmins - By Jim Cornall

biomaterials being used in tissue engineering such as repairing a heart

In Depth 10 Jan 2023

Innovative biomaterials are revolutionizing tissue regeneration

Scientists are increasingly realizing the potential of biomaterials to help with many tasks. A key area biomaterials are being used in is tissue engineering and regeneration, something several biotechs and academic labs are currently exploring. Biomaterials are materials or substances designed to function in a biological environment, which may or may not be made of […]

January 10, 2023 - 14 minutesmins - By Helen Albert

ADVERTISEMENT